Is TNF-α gene polymorphism related to pulmonary functions and prognosis as determined by FEV1, BMI, COPD exacerbation and hospitalization in patients with smoking-related COPD in a Turkish population?;Estará o polimorfismo do gene TNF-α relacionado com a função pulmonar e o prognóstico determinados pelo VEMS, IMC, exacerbações e hospitalizações em doentes com DPOC associados ao tabagismo numa população turca?

Revista Portuguesa de Pneumologia

Volumn 20, Issue 6, 2014, Pages 305-310

  Özdoğan, Nezihe ^a   Tutar, Nuri ^a   Demir, Ramazan ^a   Saatçi, Çetin ^a   Kanbay, Asiye ^a   Büyükoğlan, Hakan ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Chronic obstructive pulmonary disease; Genetics; Polymorphism; Tumor necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BODY MASS; CAUCASIAN; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; DNA POLYMORPHISM; FORCED EXPIRATORY VOLUME; GENOTYPE; HOSPITALIZATION; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROGNOSIS; SMOKING; TURKISH CITIZEN; ADVERSE EFFECTS; DISEASE COURSE; GENETIC POLYMORPHISM; GENETICS; LUNG; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TURKEY;

BODY MASS INDEX; DISEASE PROGRESSION; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMANS; LUNG; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; TUMOR NECROSIS FACTOR-ALPHA; TURKEY;

EID: 84920682447     PISSN: 08732159     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rppneu.2014.03.003     Document Type: Article

References (36)

1. Mannino D.M., Homa D.M., Akinbami L.J., Ford E.S., Redd S.C. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveill Summ 2002, 51:1-16.
2. Silverman E.K. Genetic epidemiology of COPD. Chest 2002, 121(3 Suppl.):1-6.
3. Sandford A.J., Silverman E.K. Chronic obstructive pulmonary disease: susceptibility factors for COPD the genotype environment interaction. Thorax 2002, 57:736-741.
4. Koyama H., Geddes D.M. Genes oxidative stress, and the risk of chronic obstructive pulmonary disease. Thorax 1998, 53(2 Suppl.):10-14.
5. Keatings V.M., Collins P.D., Scott D.M., Barnes P.J. Differences in interleukin-8 and tumor necrosis factor-a in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996, 153:530-534.
6. Churg A., Wang R.D., Tai H., et al. Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumour necrosis factor-a release. Am J Respir Crit Care Med 2003, 167:1083-1089.
7. Mueller R., Chanez P., Campbell A.M., Bousquet J., Heusser C., Bullock G.R. Different cytokine patterns in bronchial biopsies in asthma and chronic bronchitis. Respir Med 1996, 90:79-85.
8. Wilson A.G., Di Giovine F.S., Blakemore A.I.F., Duff G.W. Single base polymorphism in the human TNF-a gene detectable by Nco1 restriction of PCR product. Hum Mol Genet 1992, 1:353.
9. Kroeger K.M., Carville K.S., Abraham L.J. The -308 tumor necrosis factor-a promoter polymorphism effects transcription. Mol Immunol 1997, 34:391-399.
10. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., Duff G.W. Effects of a polymorphism in the human tumor necrosis factor-a promoter on transcriptional activation. Proc Natl Acad Sci USA 1997, 94:3195-3199.
11. Zhan P., Wang J., Wei S.Z., et al. TNF-308 gene polymorphism is associated with COPD risk among Asians: meta-analysis of data for 6,118 subjects. Mol Biol Rep 2011, 38:219-227.
12. Keatings V.M., Cave S.J., Henry M.J., Morgan K., O'Connor C.M., FitzGerald M.X. A polymorphism in the tumor necrosis factor-a gene promoter region may predispose to a poor prognosis in COPD. Chest 2000, 118:971-975.
13. Gingo M.R., Silveira L.J., Miller Y.E., et al. Tumour necrosis factor gene polymorphisms are associated with COPD. Eur Respir J 2008, 31:1005-1012.
14. Chen Y.C., Liu S.F., Chin C.H., et al. Association of tumor necrosis factor-alpha-863C/A gene polymorphism with chronic obstructive pulmonary disease. Lung 2010, 188:339-347.
15. Rabe K.F., Hurd S., Anzueto A., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007, 176:532-555. Global Initiative for Chronic Obstructive Lung Disease.
16. Standardization of spirometry 1994 update. Am J Respir Crit Care Med 1995, 152:1107-1136. American Thoracic Society.
17. Sakao S., Tatsumi K., Igari H., Shino Y., Shirasawa H., Kuriyama T. Association of tumor necrosis factor a gene promoter polymorphism with the presence of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 163:420-422.
18. Sakao S., Tatsumi K., Igari H., Watanabe R., Shino Y., Shirasawa H. Association of tumor necrosis factor-a gene promoter polymorphism with low attenuation areas on high-resolution CT in patients with COPD. Chest 2002, 122:416-420.
19. Huang S.L., Su C.H., Chang S.C. Tumor necrosis factor-a gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med 1997, 156:1436-1439.
20. Jiang L., He B., Zhao M.W., Ning L.D., Li X.Y., Yao W.Z. Association of gene polymorphisms of tumour necrosis factor-a and interleukin-13 with chronic obstructive pulmonary disease in Han nationality in Beijing. Chin Med J 2005, 118:541-547.
21. Kucukaycan M., Van Krugten M., Pennings H.J., et al. Tumor necrosis factor-a +489G/A gene polymorphism is associated with chronic obstructive pulmonary disease. Respir Res 2002, 3:29.
22. Brøgger J., Steen V.M., Eiken H.G., Gulsvik A., Bakke P. Genetic association between COPD and polymorphisms in TNF ADRB2 and EPHX1. Eur Respir J 2006, 27:682-688.
23. Ruse C.E., Hill M.C., Tobin M., et al. Tumour necrosis factor gene complex polymorphisms in chronic obstructive pulmonary disease. Respir Med 2007, 101:340-344.
24. Patuzzo C., Gilè L.S., Zorzetto M., et al. Tumor necrosis factor gene complex in COPD and disseminated bronchiectasis. Chest 2000, 117:1353-1358.
25. Seifart C., Dempfle A., Plagens A., et al. TNF alpha, TNF beta IL-6-, and IL-10-promoter polymorphisms in patients with chronic obstructive pulmonary disease. Tissue Antigens 2005, 65:93-100.
26. Higham M.A., Pride N.B., Alikhan A., Morrell N.W. Tumour necrosis factor-α gene promoter polymorphism in chronic obstructive pulmonary disease. Eur Respir J 2000, 15:281-284.
27. Sandford A.J., Chagani T., Weir T.D., Connett J.E., Anthonisen N.R., Paré P.D. Susceptibility genes for rapid decline of lung function in the lung health study. Am J Respir Crit Care Med 2001, 163:469-473.
28. Tanaka G., Sandford A.J., Burkett K., et al. Tumour necrosis factor and lymphotoxin a polymorphisms and lung function in smokers. Eur Respir J 2007, 29:34-41.
29. Ferrarotti I., Zorzetto M., Beccaria M., et al. Tumour necrosis factor family genes in a phenotype of COPD associated with emphysema. Eur Respir J 2003, 21:444-449.
30. Ezzeldin N., Shalaby A., Saad-Hussein A., et al. Association of TNF-α-308G/A, SP-B 1580C/T IL-13-1055C/T gene polymorphisms and latent adenoviral infection with chronic obstructive pulmonary disease in an Egyptian population. Arch Med Sci 2012, 8:286-295.
31. Hersh C.P., Demeo D.L., Lange C., et al. Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. Am J Respir Cell Mol Biol 2005, 33:71-78.
32. Melek K., Ulubay G., Sarinç Ulaşli S., Verdi H., Ataç B., Öner Eyüboğlu F. Associations between TGF-β1 G/A and TNF-α 308 G/A gene polymorphisms with airway resistance in chronic obstructive pulmonary disease. Tuberk Toraks 2013, 61:1-11. [Article in Turkish].
33. Young R.P., Hopkins R., Black P.N., et al. Functional variants of antioxidant genes in smokers with COPD and in those with normal lung function. Thorax 2006, 61:394-399.
34. Vestbo J., Prescott E., Almdal T., et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006, 173:79-83.
35. Wilson D.O., Rogers M.R., Wright E.C., Anthonisen N.R. Body weight in chronic obstructive pulmonary disease The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis 1989, 139:1435-1438.
36. Gray-Donald K., Gibbons L., Shapiro S.H., Macklem P.T., Martin J.G. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996, 153:961-966.